James R. Kasinger sold $51K of CRSP stock

James R. Kasinger, General Counsel and Secretary of CRISPR Therapeutics AG (CRSP), sold 1,040 shares of CRSP stock worth $51K, per an SEC Form 4 filed Oct 15, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Oct 13, 2026, 2 days before it was made public.

CRSP has moved -3.1% since the trade date, from $50.10 to $48.56 (Nov 5, 2026 close).